Reviews

Progress in autologous fat grafting for scar treatment

  • Xifeng AN ,
  • Xuan LIAO ,
  • Hongwei LIU
Expand
  • Department of Plastic and Reconstructive Surgery,the First Affiliated Hospital of Jinan University,Jinan University,Institute of New Technology in Plastic and Reconstructive Surgery,China Key Laboratory of Plastic and Reconstructive Surgery,Ministry of Education,Guangzhou 510630,Guangdong,China

Received date: 2025-02-26

  Online published: 2025-05-20

Abstract

Scarring is a key issue in plastic surgery research and there are limitations in the clinical outcomes of existing scar treatments. Autologous fat grafting is a new method that has been clinically proven to be effective in the treatment of pathological scarring. Autologous fat grafts contain adipose-derived mesenchymal stem cells and a variety of active factors that can effectively improve the appearance, texture and local symptoms of keloid scars through the mechanisms of immunomodulation of the inflammatory response, pro-angiogenesis, pro-cellular differentiation, extracellular matrix remodelling and resistance to oxidative stress damage, etc. It has the advantages of fewer complications and better therapeutic effect, and is a brand new field of keloid scar, which provides a new therapeutic direction for the keloid scar. The new field of scar treatment provides a new direction for scar treatment. The application and mechanism of autologous fat grafting in keloid scar is now reviewed, with the aim of providing a theoretical basis for the treatment of keloid scar and summarising the progress of its application in keloid scar treatment.

Cite this article

Xifeng AN , Xuan LIAO , Hongwei LIU . Progress in autologous fat grafting for scar treatment[J]. The Journal of Practical Medicine, 2025 , 41(9) : 1425 -1432 . DOI: 10.3969/j.issn.1006-5725.2025.09.022

References

1 HAN F, WANG K, SHEN K, et al. Extracellular vesicles from Lactobacillus druckerii inhibit hypertrophic scar fibrosis [J]. J Nanobiotechnol, 2023, 21(1): 113. doi:10.1186/s12951-023-01861-y
2 LESZCZYNSKI R, SILVA C A DA, PINTO A, et al. Laser therapy for treating hypertrophic and keloid scars [J]. Cochrane Database Syst Rev, 2022, 9(9): Cd011642. doi:10.1002/14651858.cd011642.pub2
3 HUANG R L, LIU C, FU R, et al. Downregulation of PLK4 expression induces apoptosis and G0/G1-phase cell cycle arrest in keloid fibroblasts [J]. Cell Prolif, 2022, 55(7): e13271. doi:10.1111/cpr.13271
4 NG K L B, HSIEH M W, LIN Y N, et al. Application of nanofat grafting to rescue a severe ischaemic hand with thromboangiitis obliterans: A case report about promising salvage procedure [J]. Medicine (Baltimore), 2021, 100(42): e27577. doi:10.1097/md.0000000000027577
5 宫焱熹, 韩璇, 曹毅, 等. 自体脂肪移植联合浓缩生长因子——面部年轻化的新探索 [J]. 中国美容整形外科杂志, 2024, 35(6): 374-376+389. doi:10.3969/j.issn.1673-7040.2024.06.016
6 XIE F, TENG L, LU J, et al. Interleukin-10-Modified Adipose-Derived Mesenchymal Stem Cells Prevent Hypertrophic Scar Formation via Regulating the Biological Characteristics of Fibroblasts and Inflammation [J]. Mediators Inflamm, 2022, 2022: 6368311. doi:10.1155/2022/6368311
7 温慧, 李智. 自体脂肪胶联合点阵激光治疗增生性瘢痕的临床研究 [J]. 中国现代医学杂志, 2025, 35(2): 1-6. doi:10.3969/j.issn.1005-8982.2025.02.001
8 PUTRI K T, PRASETYONO T O H. A critical review on the potential role of adipose-derived stem cells for future treatment of hypertrophic scars [J]. J Cosmet Dermatol, 2022, 21(5): 1913-1919. doi:10.1111/jocd.14385
9 叶亮 易, 王江文. A型肉毒毒素防治病理性瘢痕的临床研究进展[J]. 实用医学杂志, 2021, 37(4): 538-541.
10 张晨颖, 张高飞, 娄涵潇, 等. 剥脱性二氧化碳点阵激光在烧烫伤瘢痕中的临床应用研究进展 [J]. 实用医学杂志, 2021, 37(19): 2554-2558. doi:10.3969/j.issn.1006
11 王硕王,蒋邦红,韩娜,等. 硅凝胶联合1 565 nm非剥脱点阵激光在面部急诊外伤后瘢痕治疗中的疗效观察 [J]. 实用医学杂志, 2023, 39(19): 2511-2516. doi:10.3969/j.issn.1006-5725.2023.19.017
12 BROWN J C, SHANG H, YANG N, et al. Autologous Fat Transfer for Scar Prevention and Remodeling: A Randomized, Blinded, Placebo-controlled Trial [J]. Plast Reconstr Surg Glob Open, 2020, 8(5): e2830. doi:10.1097/gox.0000000000002830
13 LE J M, BOSWORTH J W, HONEYWELL B, et al. Adipose Grafting for Volume and Scar Release [J]. Ann Plast Surg, 2021, 86(6S ): S487-s90. doi:10.1097/sap.0000000000002873
14 HANSON S E. The Future of Fat Grafting [J]. Aesthet Surg J, 2021, 41(): S69-s74. doi:10.1093/asj/sjab130
15 JAN S N, BASHIR M M, KHAN F A, et al. Unfiltered Nanofat Injections Rejuvenate Postburn Scars of Face [J]. Ann Plast Surg, 2019, 82(1): 28-33. doi:10.1097/sap.0000000000001631
16 RAGEH M A, EL-KHALAWANY M, IBRAHIM S M A. Autologous nanofat injection in treatment of scars: A clinico-histopathological study [J]. J Cosmet Dermatol, 2021, 20(10): 3198-204. doi:10.1111/jocd.14363
17 CHEN J, LAI L, MA K, et al. The Effect of Chyle Fat Injection on Human Hypertrophic Scars in an Animal Model: A New Strategy for the Treatment of Hypertrophic Scars [J]. Ann Plast Surg, 2019, 82(6): 622-627. doi:10.1097/sap.0000000000001784
18 AYADI A EL, JAY J W, PRASAI A. Current Approaches Targeting the Wound Healing Phases to Attenuate Fibrosis and Scarring [J]. Int J Mol Sci, 2020, 21(3): 1105. doi:10.3390/ijms21031105
19 ZHANG Q, LIU L N, YONG Q, et al. Intralesional injection of adipose-derived stem cells reduces hypertrophic scarring in a rabbit ear model [J]. Stem Cell Res Ther, 2015, 6(1): 145. doi:10.1186/s13287-015-0133-y
20 MARIA A T, TOUPET K, MAUMUS M, et al. Human adipose mesenchymal stem cells as potent anti-fibrosis therapy for systemic sclerosis [J]. J Autoimmun, 2016, 70: 31-39. doi:10.1016/j.jaut.2016.03.013
21 LI S, YANG J, SUN J, et al. Adipose-Derived Mesenchymal Stem Cells Alleviate Hypertrophic Scar by Inhibiting Bioactivity and Inducing Apoptosis in Hypertrophic Scar Fibroblasts [J]. Cells, 2022, 11(24): 4024. doi:10.3390/cells11244024
22 JATIN B, KARKI D, AHLUWALIA C, et al. Lipofilling-A Regenerative Alternate for Remodeling Burn Scars: A Clinico-Immunohistopathological Study [J]. Indian J Plast Surg, 2023, 56(4): 357-366. doi:10.1055/s-0043-1771515
23 STACHURA A, PASKAL W, PAWLIK W, et al. The Use of Adipose-Derived Stem Cells (ADSCs) and Stromal Vascular Fraction (SVF) in Skin Scar Treatment-A Systematic Review of Clinical Studies [J]. J Clin Med, 2021, 10(16): 3637. doi:10.3390/jcm10163637
24 MCKINNIREY F, HERBERT B, VESEY G, et al. Immune modulation via adipose derived Mesenchymal Stem cells is driven by donor sex in vitro [J]. Sci Rep, 2021, 11(1): 12454. doi:10.1038/s41598-021-91870-4
25 AL-GHADBAN S, BUNNELL B A. Adipose Tissue-Derived Stem Cells: Immunomodulatory Effects and Therapeutic Potential [J]. Physiology (Bethesda), 2020, 35(2): 125-133. doi:10.1152/physiol.00021.2019
26 MAZINI L, ROCHETTE L, ADMOU B, et al. Hopes and Limits of Adipose-Derived Stem Cells (ADSCs) and Mesenchymal Stem Cells (MSCs) in Wound Healing [J]. Int J Mol Sci, 2020, 21(4): 1306. doi:10.3390/ijms21041306
27 MIK?OSZ A, NIKITIUK B E, CHABOWSKI A. Using adipose-derived mesenchymal stem cells to fight the metabolic complications of obesity: Where do we stand? [J]. Obes Rev, 2022, 23(5): e13413. doi:10.1111/obr.13413
28 JOHNSON B Z, STEVENSON A W, PRêLE C M, et al. The Role of IL-6 in Skin Fibrosis and Cutaneous Wound Healing [J]. Biomedicines, 2020, 8(5): 101. doi:10.3390/biomedicines8050101
29 LI D, LI X, ZHANG J, et al. The immunomodulatory effect of IL-4 accelerates bone substitute material-mediated osteogenesis in aged rats via NLRP3 inflammasome inhibition [J]. Front Immunol, 2023, 14: 1121549. doi:10.3389/fimmu.2023.1121549
30 TING H K, CHEN C L, MENG E, et al. Inflammatory Regulation by TNF-α-Activated Adipose-Derived Stem Cells in the Human Bladder Cancer Microenvironment [J]. Int J Mol Sci, 2021, 22(8): 3987. doi:10.3390/ijms22083987
31 XIA T, ZHANG M, LEI W, et al. Advances in the role of STAT3 in macrophage polarization [J]. Front Immunol, 2023, 14: 1160719. doi:10.3389/fimmu.2023.1160719
32 HU X, LI J, FU M, et al. The JAK/STAT signaling pathway: from bench to clinic [J]. Signal Transduct Target Ther, 2021, 6(1): 402. doi:10.1038/s41392-021-00791-1
33 KRASKIEWICZ H, HINC P, KRAWCZENKO A, et al. HATMSC Secreted Factors in the Hydrogel as a Potential Treatment for Chronic Wounds-In Vitro Study [J]. Int J Mol Sci, 2021, 22(22): 12241. doi:10.3390/ijms222212241
34 KRAWCZENKO A, BIELAWSKA-POHL A, PAPROCKA M, et al. Microvesicles from Human Immortalized Cell Lines of Endothelial Progenitor Cells and Mesenchymal Stem/Stromal Cells of Adipose Tissue Origin as Carriers of Bioactive Factors Facilitating Angiogenesis [J]. Stem Cells Int, 2020, 2020: 1289380. doi:10.1155/2020/1289380
35 KRASKIEWICZ H, PAPROCKA M, BIELAWSKA-POHL A, et al. Can supernatant from immortalized adipose tissue MSC replace cell therapy? An in vitro study in chronic wounds model [J]. Stem Cell Res Ther, 2020, 11(1): 29. doi:10.1186/s13287-020-1558-5
36 KRAWCZENKO A, KLIMCZAK A. Adipose Tissue-Derived Mesenchymal Stem/Stromal Cells and Their Contribution to Angiogenic Processes in Tissue Regeneration [J]. Int J Mol Sci, 2022, 23(5): 2425. doi:10.3390/ijms23052425
37 WANG Q, ZHOU M, ZHANG H, et al. Hypoxia Treatment of Adipose Mesenchymal Stem Cells Promotes the Growth of Dermal Papilla Cells via HIF-1α and ERK1/2 Signaling Pathways [J]. Int J Mol Sci, 2023, 24(13): 11198. doi:10.3390/ijms241311198
38 FAROOQ M, KHAN A W, KIM M S, et al. The Role of Fibroblast Growth Factor (FGF) Signaling in Tissue Repair and Regeneration [J]. Cells, 2021, 10(11): 3242. doi:10.3390/cells10113242
39 MANNINO G, LONGO A, GENNUSO F, et al. Effects of High Glucose Concentration on Pericyte-Like Differentiated Human Adipose-Derived Mesenchymal Stem Cells [J]. Int J Mol Sci, 2021, 22(9): 4604. doi:10.3390/ijms22094604
40 BELOGLAZOVA I, STEPANOVA V, ZUBKOVA E, et al. Mesenchymal stromal cells enhance self-assembly of a HUVEC tubular network through uPA-uPAR/VEGFR2/integrin/NOTCH crosstalk [J]. Biochim Biophys Acta Mol Cell Res, 2022, 1869(1): 119157. doi:10.1016/j.bbamcr.2021.119157
41 HU Y, XIONG Y, ZHU Y, et al. Copper-Epigallocatechin Gallate Enhances Therapeutic Effects of 3D-Printed Dermal Scaffolds in Mitigating Diabetic Wound Scarring [J]. ACS Appl Mater Interfaces, 2023, 15(32): 38230-38246. doi:10.1021/acsami.3c04733
42 ZHA K, TIAN Y, PANAYI A C, et al. Recent Advances in Enhancement Strategies for Osteogenic Differentiation of Mesenchymal Stem Cells in Bone Tissue Engineering [J]. Front Cell Dev Biol, 2022, 10: 824812. doi:10.3389/fcell.2022.824812
43 JI F, WANG Y, YUAN J, et al. The potential role of stromal cell-derived factor-1α/CXCR4/CXCR7 axis in adipose-derived mesenchymal stem cells [J]. J Cell Physiol, 2020, 235(4): 3548-3557. doi:10.1002/jcp.29243
44 LI C, WEI S, XU Q, et al. Application of ADSCs and their Exosomes in Scar Prevention [J]. Stem Cell Rev Rep, 2022, 18(3): 952-967. doi:10.1007/s12015-021-10252-5
45 AIRUDDIN S S, HALIM A S, WAN SULAIMAN W A, et al. Adipose-Derived Stem Cell: "Treat or Trick" [J]. Biomedicines, 2021, 9(11): 1624. doi:10.3390/biomedicines9111624
46 XIE C, MONDAL D K, ULAS M, et al. Oncosuppressive roles of decorin through regulation of multiple receptors and diverse signaling pathways [J]. Am J Physiol Cell Physiol, 2022, 322(3): C554-C66. doi:10.1152/ajpcell.00016.2022
47 BYRNE M, O'DONNELL M, FITZGERALD L, et al. Early experience with fat grafting as an adjunct for secondary burn reconstruction in the hand: Technique, hand function assessment and aesthetic outcomes [J]. Burns, 2016, 42(2): 356-365. doi:10.1016/j.burns.2015.06.017
48 KLINGER M, MARAZZI M, VIGO D, et al. Fat Injection for Cases of Severe Burn Outcomes: A New Perspective of Scar Remodeling and Reduction [J]. Aesthetic Plast Surg, 2020, 44(4): 1278-1282. doi:10.1007/s00266-020-01813-z
49 KOONCE S L, GRANT D G, COOK J, et al. Autologous Fat Grafting in the Treatment of Cleft Lip Volume Asymmetry [J]. Ann Plast Surg, 2018, 80(6S): S352-S355. doi:10.1097/sap.0000000000001348
50 RIBUFFO D, ATZENI M, GUERRA M, et al. Treatment of irradiated expanders: protective lipofilling allows immediate prosthetic breast reconstruction in the setting of postoperative radiotherapy [J]. Aesthetic Plast Surg, 2013, 37(6): 1146-1152. doi:10.1007/s00266-013-0221-2
51 TANWAR V, PUSHKER N, AGRAWAL S, et al. Autologous fat grafting for the correction of cicatricial ectropion [J]. J Plast Reconstr Aesthet Surg, 2022, 75(12): 4496-512. doi:10.1016/j.bjps.2022.10.004
Outlines

/